Next Article in Journal
A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors
Previous Article in Journal
Contrasting Roles of Programmed Death-Ligand 1 Expression in Tumor and Stroma in Prognosis of Esophageal Squamous Cell Carcinoma
Previous Article in Special Issue
Survival Benefit of Renin-Angiotensin System Blockers in Critically Ill Cancer Patients: A Retrospective Study
 
 
Systematic Review

Article Versions Notes

Cancers 2024, 16(6), 1136; https://doi.org/10.3390/cancers16061136
Action Date Notes Link
article xml file uploaded 13 March 2024 09:41 CET Original file -
article xml uploaded. 13 March 2024 09:41 CET Update https://www.mdpi.com/2072-6694/16/6/1136/xml
article pdf uploaded. 13 March 2024 09:41 CET Version of Record https://www.mdpi.com/2072-6694/16/6/1136/pdf
article supplementary file uploaded. 13 March 2024 09:41 CET - https://www.mdpi.com/2072-6694/16/6/1136#supplementary
article html file updated 13 March 2024 09:42 CET Original file https://www.mdpi.com/2072-6694/16/6/1136/html
Back to TopTop